146 related articles for article (PubMed ID: 25154256)
1. [Recent progress of diagnosis and treatment for immune-mediated hematological diseases. Topics: III. Diagnosis and treatment; 4. Thrombotic thrombocytopenic purpura].
Matsumoto M
Nihon Naika Gakkai Zasshi; 2014 Jul; 103(7):1613-21. PubMed ID: 25154256
[No Abstract] [Full Text] [Related]
2. Acquired thrombotic thrombocytopenic purpura: ADAMTS13 activity, anti-ADAMTS13 autoantibodies and risk of recurrent disease.
Lämmle B; Kremer Hovinga JA; George JN
Haematologica; 2008 Feb; 93(2):172-7. PubMed ID: 18245649
[No Abstract] [Full Text] [Related]
3. [Thrombotic Thrombocytopenic Purpura --Pathophysiology and Assays of ADAMTS13 Activity].
Kato S; Fujimura Y
Rinsho Byori; 2015 Oct; 63(10):1228-36. PubMed ID: 26897861
[TBL] [Abstract][Full Text] [Related]
4. ADAMTS13 and von Willebrand factor in thrombotic thrombocytopenic purpura.
Zheng XL
Annu Rev Med; 2015; 66():211-25. PubMed ID: 25587650
[TBL] [Abstract][Full Text] [Related]
5. ADAMTS13 and anti-ADAMTS13 autoantibodies in thrombotic thrombocytopenic purpura - current perspectives and new treatment strategies.
Tersteeg C; Verhenne S; Roose E; Schelpe AS; Deckmyn H; De Meyer SF; Vanhoorelbeke K
Expert Rev Hematol; 2016; 9(2):209-21. PubMed ID: 26581428
[TBL] [Abstract][Full Text] [Related]
6. ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission.
Peyvandi F; Lavoretano S; Palla R; Feys HB; Vanhoorelbeke K; Battaglioli T; Valsecchi C; Canciani MT; Fabris F; Zver S; Réti M; Mikovic D; Karimi M; Giuffrida G; Laurenti L; Mannucci PM
Haematologica; 2008 Feb; 93(2):232-9. PubMed ID: 18223285
[TBL] [Abstract][Full Text] [Related]
7. Thrombotic thrombocytopenic purpura.
Burle S; Passi GR; Salgia P; Modi A
Indian Pediatr; 2004 Mar; 41(3):277-9. PubMed ID: 15064518
[TBL] [Abstract][Full Text] [Related]
8. Advances in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura.
Tsai HM
J Am Soc Nephrol; 2003 Apr; 14(4):1072-81. PubMed ID: 12660343
[TBL] [Abstract][Full Text] [Related]
9. Thrombotic thrombocytopenic purpura and other thrombotic microangiopathic hemolytic anemias: diagnosis and classification.
Shenkman B; Einav Y
Autoimmun Rev; 2014; 13(4-5):584-6. PubMed ID: 24418304
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura.
Tsai HM; Lian EC
N Engl J Med; 1998 Nov; 339(22):1585-94. PubMed ID: 9828246
[TBL] [Abstract][Full Text] [Related]
11. ADAMTS13 antibody depletion by bortezomib in thrombotic thrombocytopenic purpura.
Shortt J; Oh DH; Opat SS
N Engl J Med; 2013 Jan; 368(1):90-2. PubMed ID: 23281998
[No Abstract] [Full Text] [Related]
12. Thrombotic thrombocytopenic purpura: a simpler diagnosis at last?
Mannucci PM
Thromb Haemost; 1999 Nov; 82(5):1380-1. PubMed ID: 10595621
[No Abstract] [Full Text] [Related]
13. A 9-month-old infant with acquired idiopathic thrombotic thrombocytopenic purpura caused by inhibitory IgG-autoantibody to ADAMTS13.
Sato A; Hoshi Y; Onuma M; Sato R; Tsunematsu Y; Isonishi A; Matsumoto M; Fujimura Y; Imaizumi M
Pediatr Hematol Oncol; 2010 Feb; 27(1):53-8. PubMed ID: 20121555
[TBL] [Abstract][Full Text] [Related]
14. Bortezomib induces clinical remission and reduction of ADAMTS13 inhibitory antibodies in relapsed refractory idiopathic thrombotic thrombocytopenic purpura.
Mazepa MA; Raval JS; Moll S; Ma A; Park YA
Br J Haematol; 2014 Mar; 164(6):900-2. PubMed ID: 24345005
[No Abstract] [Full Text] [Related]
15. Acquired thrombotic thrombocytopenic purpura. Development of an autoimmune response.
Schaller M; Studt JD; Voorberg J; Kremer Hovinga JA
Hamostaseologie; 2013 May; 33(2):121-30. PubMed ID: 23443151
[TBL] [Abstract][Full Text] [Related]
16. Simple plasma exchange reduced autoantibody to von Willebrand factor-cleaving protease in a Japanese man with ticlopidine-associated thrombotic thrombocytopenic purpura.
Orimo S; Ozawa E; Yagi H; Ishizashi H; Matsumoto M; Fujimura Y
J Intern Med; 2002 Mar; 251(3):280-1. PubMed ID: 11886490
[No Abstract] [Full Text] [Related]
17. Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP).
Gerritsen HE; Turecek PL; Schwarz HP; Lämmle B; Furlan M
Thromb Haemost; 1999 Nov; 82(5):1386-9. PubMed ID: 10595623
[TBL] [Abstract][Full Text] [Related]
18. Thrombotic thrombocytopenic purpura and its imitators.
Braverman AS
South Med J; 2009 May; 102(5):455-6. PubMed ID: 19373136
[No Abstract] [Full Text] [Related]
19. Analyses of ADAMTS13 activity and its inhibitor in patients with thrombotic thrombocytopenic purpura secondary to connective tissue diseases: Observations in a single hospital.
Sato T; Hanaoka R; Ohshima M; Miwa Y; Okazaki Y; Yajima N; Ishizashi H; Matsumoto M; Fujimura Y; Inokuma S
Clin Exp Rheumatol; 2006; 24(4):454-5. PubMed ID: 16956441
[No Abstract] [Full Text] [Related]
20. Thrombotic thrombocytopenic purpura associated with statin therapy.
Thomas MR; McDonald V; Machin SJ; Scully MA
Blood Coagul Fibrinolysis; 2011 Dec; 22(8):762-3. PubMed ID: 22198366
[No Abstract] [Full Text] [Related]
[Next] [New Search]
